D.E. Shaw & Co’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $705K | Sell |
195,852
-148,693
| -43% | -$535K | ﹤0.01% | 2391 |
|
|
2025
Q1 | $1.03M | Buy |
344,545
+88,462
| +35% | +$265K | ﹤0.01% | 2162 |
|
|
2024
Q4 | $858K | Buy |
256,083
+62,505
| +32% | +$209K | ﹤0.01% | 2170 |
|
|
2024
Q3 | $648K | Buy |
193,578
+45,665
| +31% | +$153K | ﹤0.01% | 2369 |
|
|
2024
Q2 | $490K | Sell |
147,913
-59,846
| -29% | -$198K | ﹤0.01% | 2499 |
|
|
2024
Q1 | $839K | Buy |
207,759
+22,582
| +12% | +$91.2K | ﹤0.01% | 2190 |
|
|
2023
Q4 | $565K | Buy |
185,177
+115,228
| +165% | +$351K | ﹤0.01% | 2317 |
|
|
2023
Q3 | $210K | Sell |
69,949
-13,473
| -16% | -$40.4K | ﹤0.01% | 2571 |
|
|
2023
Q2 | $312K | Buy |
83,422
+33,724
| +68% | +$126K | ﹤0.01% | 2477 |
|
|
2023
Q1 | $166K | Buy |
49,698
+9,476
| +24% | +$31.7K | ﹤0.01% | 2839 |
|
|
2022
Q4 | $193K | Buy |
40,222
+11,065
| +38% | +$53.2K | ﹤0.01% | 3039 |
|
|
2022
Q3 | $166K | Buy |
+29,157
| New | +$166K | ﹤0.01% | 3248 |
|
|
2022
Q1 | – | Sell |
-19,404
| Closed | -$173K | – | 4241 |
|
|
2021
Q4 | $173K | Buy |
+19,404
| New | +$173K | ﹤0.01% | 3534 |
|
|
2021
Q2 | – | Sell |
-28,187
| Closed | -$1.74M | – | 3523 |
|
|
2021
Q1 | $1.74M | Buy |
+28,187
| New | +$1.74M | ﹤0.01% | 1915 |
|